treatment [ftcn]
Hypertension [dsyn]
peripheral arterial disease [dsyn]
peripheral arterial disease [dsyn]
Morbidity [qnco]
Mortality [qnco]
Hypertension [dsyn]
peripheral arterial disease [dsyn]
treatment [ftcn]
Hypertension [dsyn]
compatible [idcn]
symptoms [ftcn]
peripheral arterial disease [dsyn]
controversy [socb]
effects [qlco]
Beta [plnt]
adrenoreceptor [aapp, rcpt]
Blockade [ftcn]
Hypertension [dsyn]
Patients [podg]
peripheral arterial disease [dsyn]
LED [mnob]
Physicians [prog]
Stop [acty]
prescribing [hlca]
Beta-Blockers [phsu]
adrenoreceptor [aapp, rcpt]
Little NOS [cgab, dsyn]
Known [qlco]
effects [qlco]
Class [inpr]
Anti-Hypertensive Drugs [phsu]
peripheral arterial disease [dsyn]
Second [qnco]
Update [tmco]
Published [ocac]
objectives [inpr]
effects [qlco]
Anti-Hypertensive Drugs [phsu]
Patients [podg]
Raised blood pressure [fndg]
Symptomatic [ftcn]
peripheral arterial disease [dsyn]
cardiovascular events [fndg]
symptoms [ftcn]
claudication [fndg]
Critical [qlco]
Leg [blor]
Ischaemia [dsyn]
progression [patf]
atherosclerotic [ftcn]
peripheral arterial disease [dsyn]
Measured [qlco]
Ankle Brachial Index [clna]
Need [qlco]
Revascularisation [topp]
Reconstructive Surgery [topp]
Angioplasty [topp]
Amputation [topp]
search [inpr]
Methods [inpr]
Update [tmco]
Peripheral Vascular Diseases [dsyn]
Group [idcn]
Trial [resa]
search [inpr]
Searched [acty]
Peripheral Vascular Diseases [dsyn]
Group [idcn]
specialised [qlco]
Last [qlco]
Searched [acty]
Central [spco]
Issue [fndg]
Selection Criteria [qlco]
Controlled [ftcn]
Trial [resa]
anti hypertensive [phsu]
treatment [ftcn]
placebo [topp]
anti hypertensive [phsu]
Medications [phsu]
interventions [hlca]
Last [qlco]
Trial [resa]
Patients [podg]
Symptomatic [ftcn]
peripheral arterial disease [dsyn]
Data Collection [resa]
Extracted [topp]
Author [prog]
DAL [carb, phsu]
Checked [acty]
eligible [idcn]
Excluded [idcn]
Presentation [idcn]
PREVENT [phsu]
Adequate [qlco]
Extraction [topp]
Authors [prog]
R AW [ortf]
Main [qlco]
Eight [qnco]
Controlled [ftcn]
Trial [resa]
included [ftcn]
peripheral arterial disease [dsyn]
Patients [podg]
Compared [acty]
Class [inpr]
anti hypertensive [phsu]
treatment [ftcn]
placebo [topp]
Study [mnob]
Compared [acty]
anti hypertensive [phsu]
Treatments [topp]
Pooled [cnce]
Variation [qlco]
Comparison [acty]
Presented [idcn]
Quality [qlco]
Available [ftcn]
lack [qlco]
Detail [qlco]
Study [mnob]
Report [inpr]
Randomization [resa]
Blinding [resa]
procedures [inpr]
incomplete data [idcn]
Study [mnob]
Compared [acty]
Angiotensin-Converting Enzyme Inhibitors [phsu]
placebo [topp]
Study [mnob]
reduction [npop]
cardiovascular events [fndg]
Patients [podg]
Receive [qlco]
Ramipril [orch, phsu]
Odds Ratio [qnco]
N NOS [aapp, imft]
Second [qnco]
Trial [resa]
Perindopril [orch, phsu]
N NOS [aapp, imft]
Marginal [spco]
Claudication distance [fndg]
Ankle Brachial Index [clna]
reduction [npop]
Maximum [qnco]
Walking distance [fndg]
Trial [resa]
calcium antagonist [phsu]
Verapamil [orch, phsu]
placebo [topp]
Patients [podg]
Angioplasty [topp]
N NOS [aapp, imft]
Suggest [idcn]
Verapamil [orch, phsu]
Reduced [qlco]
Restenosis [acab]
Percent [qnco]
Diameter [qnco]
Stenosis [patf]
SD [fndg]
P NOS [aapp, imft]
reflected [menp]
Maintenance [acty]
Ankle Brachial Index [clna]
Verapamil [orch, phsu]
placebo [topp]
Study [mnob]
N NOS [aapp, imft]
Arterial [bpoc]
Intima media thickness [clna]
Men [popg]
Receive [qlco]
Thiazide diuretic [orch, phsu]
Hydrochlorothiazide [orch, phsu]
Compared [acty]
Receive [qlco]
Alpha Blocker [phsu]
adrenoreceptor [aapp, rcpt]
Doxazosin [orch, phsu]
P NOS [aapp, imft]
Study [mnob]
N NOS [aapp, imft]
telmisartan [orch, phsu]
placebo [topp]
Improvement [cnce]
Maximum [qnco]
Walking distance [fndg]
months [tmco]
telmisartan [orch, phsu]
Interquartile Range [qnco]
M NOS [aapp, imft]
M NOS [aapp, imft]
P NOS [aapp, imft]
Ankle Brachial Index [clna]
Interquartile Range [qnco]
Arterial [bpoc]
Intima media thickness [clna]
Interquartile Range [qnco]
Compared [acty]
Beta-blocker [phsu]
adrenoreceptor [aapp, rcpt]
nebivolol [orch, phsu]
Thiazide diuretic [orch, phsu]
Hydrochlorothiazide [orch, phsu]
Metoprolol [orch, phsu]
Intermittent [tmco]
Absolute [qlco]
Claudication distance [fndg]
Ankle Brachial Index [clna]
Mortality [qnco]
Anti-Hypertensives [phsu]
subgroup [virs]
peripheral arterial disease [dsyn]
Patients [podg]
N NOS [aapp, imft]
Study [mnob]
Compared [acty]
calcium antagonist [phsu]
Based [ftcn]
strategy [menp]
verapamil trandolapril [orch, phsu]
Slow [qlco]
Release [hlca]
Beta-blocker [phsu]
adrenoreceptor [aapp, rcpt]
Based [ftcn]
strategy [menp]
Atenolol [orch, phsu]
Hydrochlorothiazide [orch, phsu]
Composite [qlco]
endpoints [qlco]
Fatal [qlco]
Myocardial Infarction [dsyn]
Fatal [qlco]
Stroke [dsyn]
Revascularisation [topp]
Odds Ratio [qnco]
>90 [qnco]
Odds Ratio [qnco]
Authors [prog]
Conclusions [idcn]
Various [irda]
Anti-Hypertensive Drugs [phsu]
People [popg]
peripheral arterial disease [dsyn]
Unknown [qlco]
Benefits [qnco]
lack [qlco]
examining [fndg]
peripheral arterial disease [dsyn]
Patients [podg]
Benefit [qnco]
treating [topp]
Hypertension [dsyn]
lower blood pressure [fndg]
